Switzerland· 58644002
Urispas, Filmtabletten
A flavoxate product containing flavoxati hydrochloridum, registered in Switzerland by RECORDATI AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Flavoxate is registered in 7 of 19 countries.
Countries holding a registration under ATC G04BD02 (flavoxate), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 3 of them publish a price we can compare per daily dose
Flavoxate · ATC G04BD02
7 / 19 countries
- Belgiumprice
- Germany
- Ireland
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flavoxate costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- Switzerland: $2.26 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Flavoxate · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.26
The record
At a glance
Swissmedic (Switzerland)- Active substance
- flavoxati hydrochloridum
- Manufacturer
- RECORDATI AG
- Country
- Switzerland (CH)
- ATC code
- G04BD02
- ATC class
- Flavoxate
- Defined daily dose
- 0.8 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680586440020100 StkCHF 37.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
132 interactions on record for flavoxate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flavoxate · interactions on record
132 records
- 3 severe
- 89 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
39 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flavoxate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainURONID 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULACasen Recordati S.L.
- FranceURISPAS 200 mg, comprimé pelliculéBOUCHARA-RECORDATI
- IrelandUrispas 200 mg Film-coated TabletsRecordati Ireland Limited
- United KingdomFlavoxate 100mg/5ml oral solutionSpecial Order
- United StatesFlavoxate HydrochlorideEpic Pharma, LLC
- GermanySpasuret 200 MgRecordati Pharma Gmbh
- BelgiumUrispas 200 mgRecordati Ireland
- NetherlandsUrispas, omhulde tabletten 200 mgRecordati Ireland Ltd. (Co. Cork)
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Urispas
- Germany · Spasuret 200 Mg
- Spain · Uronid
- France · Urispas
- United Kingdom (Northern Ireland) · Urispas
- Ireland · Urispas
- Italy · Genurin
- Lithuania · Urispas
- Luxembourg · Urispas
- Netherlands · Urispas
- Portugal · Urispás
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4407550c-8001-4a32-8df5-bba7c5eb01d6 GET /v1/drugs/4407550c-8001-4a32-8df5-bba7c5eb01d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "flavoxati hydrochloridum 200 mg",
"valid_from": "2009-05-01",
"limitations": null,
"galenic_form": "Filmtabl 200 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2009-05-01",
"self_retention_pct": 10
}See everything about flavoxate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.